TheNote.app
Sign In
Sign Up
RSS European Medicines Agency (EMA) | Human medicine and SMOPs
Human medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of authorisation: 24/03/2023, Revision: 3, Status: Authorised
www.ema.europa.eu
www.ema.europa.eu
